Health Care & Life Sciences » Biotechnology | Fortress Biotech Inc.

Fortress Biotech Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
99,521.00
69,761.00
98,182.00
91,681.00
152,943.00
83,112
Total Accounts Receivable
-
-
-
8,689.00
17,387.00
7,593
Inventories
-
-
-
203.00
171.00
678
Other Current Assets
510.00
702.00
1,597.00
9,061.00
12,680.00
19,824
Total Current Assets
100,031.00
70,463.00
99,779.00
109,634.00
183,181.00
111,207
Net Property, Plant & Equipment
447.00
52.00
309.00
7,376.00
9,513.00
12,019
Total Investments and Advances
-
18,746.00
17,071.00
17,274.00
18,777.00
16,074
Intangible Assets
-
-
1,250.00
36,053.00
33,868.00
1,417
Other Assets
104.00
70.00
201.00
394.00
611.00
276
Total Assets
100,582.00
89,331.00
118,610.00
170,731.00
245,950.00
140,993
ST Debt & Current Portion LT Debt
6,203.00
-
-
2,031.00
13,228.00
Accounts Payable
468.00
366.00
1,868.00
14,213.00
18,495.00
Other Current Liabilities
4,539.00
3,711.00
8,711.00
40,321.00
35,705.00
Total Current Liabilities
11,210.00
4,077.00
10,579.00
56,565.00
67,428.00
Long-Term Debt
7,415.00
14,009.00
23,174.00
26,184.00
53,281.00
Other Liabilities
679.00
722.00
584.00
5,014.00
4,739.00
Total Liabilities
19,304.00
18,808.00
34,337.00
87,763.00
125,448.00
Common Equity (Total)
81,278.00
70,523.00
56,846.00
38,495.00
52,572.00
Total Shareholders' Equity
81,278.00
70,523.00
56,846.00
38,495.00
52,573.00
Total Equity
81,278.00
70,523.00
84,273.00
82,968.00
120,502.00
Liabilities & Shareholders' Equity
100,582.00
89,331.00
118,610.00
170,731.00
245,950.00
Accumulated Minority Interest
-
-
27,427.00
44,473.00
67,929.00
Preferred Stock (Carrying Value)
-
-
-
-
1.00

About Fortress Biotech

View Profile
Address
2 Gansevoort Street
New York New York 10014
United States
Employees -
Website http://www.fortressbiotech.com
Updated 07/08/2019
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company.